NCT07113093Completed
The Effects of Augmented Reality Versus Virtual Reality
Effects of Augmented Reality and Virtual Reality-Assisted Gait Training on Balance and Walking in Individuals With Stroke
Source: ClinicalTrials.gov · Last updated 19 Aug 2026
Brief summary (registry, in English)
This randomized controlled trial aims to compare the effects of augmented reality (AR) and virtual reality (VR)-assisted treadmill gait training on balance and walking in individuals with stroke, within the framework of the International Classification of Functioning, Disability and Health (ICF). A total of 66 post-stroke patients will be randomly assigned to three groups: (1) VR group receiving gait training via C-Mill VR applications in addition to conventional physiotherapy, (2) AR group receiving gait training via C-Mill AR applications in addition to conventional physiotherapy, and (3) control group receiving a home exercise program alongside conventional physiotherapy. Participants will train for 45 minutes per day, five days a week, for three weeks. Outcome measures will include clinical, functional, cognitive, and spatiotemporal gait parameters to evaluate changes in balance and walking ability before and after the intervention.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 75 (actual)
- First submitted
- 30 Jul 2025
- Start date
- 1 Aug 2025
- Primary completion date
- 30 Jun 2026
- Lead sponsor
- Ankara Yildirim Beyazıt University
- Diseases
- Stroke
- NCT number
- NCT07113093
What you commit to
- Study type: Interventional
- Participants enrolled: 75
- From 1 Aug 2025 to the primary completion date, 30 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of extra neurological or orthopedic problems unrelated to stroke
- Recurrent stroke
Other
- Incomplete completion of the assessment form
- Refusal to participate in the study
- Aphasia
- Montreal Cognitive Assessment score below 10
- MAS score of 3-4 (lower extremity)
- Volunteer's desire to withdraw from the study
- Inability to adapt to the technological devices used in the study (e.g., visual or hearing impairments)
- Missing three consecutive treatment sessions
- Botulinum toxin-A (BONT-A) injection to the lower extremity during the treatment process or within the last 6 months
Who the study is looking for
- ICD-10 diagnosis code of G.81 (Hemiplegia)
- Age 18 years or older
- Ability to walk with assistance or independently (Functional Ambulation Classification score of 2 or higher)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ankara Bilkent City Hospital Coordinator of this site? Confirm its status | Ankara | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.